(19)
(11) EP 4 554 982 A1

(12)

(43) Date of publication:
21.05.2025 Bulletin 2025/21

(21) Application number: 23751224.9

(22) Date of filing: 11.07.2023
(51) International Patent Classification (IPC): 
C08B 37/00(2006.01)
C08L 5/02(2006.01)
C08L 5/00(2006.01)
A61K 8/73(2006.01)
(52) Cooperative Patent Classification (CPC):
C08B 37/0009; C08B 37/0024; C08L 5/00; A61K 8/73; A61Q 19/00; A61K 2800/10; A61Q 5/06
(86) International application number:
PCT/US2023/069938
(87) International publication number:
WO 2024/015769 (18.01.2024 Gazette 2024/03)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
KH MA MD TN

(30) Priority: 11.07.2022 US 202263359965 P

(71) Applicant: Nutrition & Biosciences USA 4, Inc.
Rochester NY 14623 (US)

(72) Inventor:
  • HUANG, Zhengzheng
    HOCKESSIN, Delaware 19707 (US)

(74) Representative: Mewburn Ellis LLP 
Aurora Building Counterslip
Bristol BS1 6BX
Bristol BS1 6BX (GB)

   


(54) AMPHIPHILIC GLUCAN ESTER DERIVATIVES